We proposed a robust strategy—to replace the conventional postfunctionalization approaches—where a PSMA‐specific gy1 is directly expressed on the macrophage membranes, which endows the MNPs with significantly increased circulation time and cell‐specific tumor targeting and internalization. The gene discussed is DGCR8; the disease is neoplasm.